ITI is a program of The Task Force for Global Health.
Yemen initiated the first phase of baseline mapping using the GTMP platform in 70 districts in 2014. From this round of surveys, 7 districts were identified for SAFE intervention in Ibb and Al Hudaydah governorates. A trachoma action plan workshop was organized in October 2014 in Cairo. In summer 2014, the TEC approved Zithromax® for the seven districts starting 2015. More districts were mapped in early 2015 but health program activities had to be suspended in March 2015 due to the civil war.
In 2017, the national program mobilized funding from a consortium of partners to launch MDAs and SAFE in six districts in Al Hudaydah and Ibb governorates that have active trachoma prevalence between 5-9.9%.
Zithromax® Shipments by Year